The Hippo pathway in clear cell renal cell carcinoma (ccRCC): a nexus with the VHL disruption?
Background: Clear cell renal cell carcinoma (ccRCC) represents 70% of kidney cancers, with 20–50% recurrence risk after surgery. Despite therapeutic advances, no reliable biomarkers have been identified for patient stratification or treatment response prediction. While VHL gene alterations are well-...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
Elsevier
2026-04-01
|
| 丛编: | Translational Oncology |
| 主题: | |
| 在线阅读: | http://www.sciencedirect.com/science/article/pii/S1936523326000586 |
| 标签: |
没有标签, 成为第一个标记此记录!
|